Literature DB >> 12724226

Epigenetics in carcinogenesis and cancer prevention.

Peter A Jones1.   

Abstract

Carcinogenesis is a stepwise process of accumulation of genetic and epigenetic abnormalities that can lead to cellular dysfunction. It has become clear that epigenetic changes are equally important for this multistep process to produce its results. This article describes the different roles that epigenetic modulation may play during carcinogenesis and how an early detection and chemopreventive intervention strategy that takes both sides of the equation into account would be advantageous.

Entities:  

Mesh:

Year:  2003        PMID: 12724226     DOI: 10.1111/j.1749-6632.2003.tb05976.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  30 in total

1.  Epigenetic silencing of somatostatin in gastric cancer.

Authors:  Kaya Jackson; Mohammed Soutto; DunFa Peng; TianLing Hu; Dana Marshal; Wael El-Rifai
Journal:  Dig Dis Sci       Date:  2010-10-07       Impact factor: 3.199

2.  Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells.

Authors:  Ben Youngblood; Kenneth J Oestreich; Sang-Jun Ha; Jaikumar Duraiswamy; Rama S Akondy; Erin E West; Zhengyu Wei; Peiyuan Lu; James W Austin; James L Riley; Jeremy M Boss; Rafi Ahmed
Journal:  Immunity       Date:  2011-09-23       Impact factor: 31.745

Review 3.  Making memories that last a lifetime: heritable functions of self-renewing memory CD8 T cells.

Authors:  Ben Youngblood; Carl W Davis; Rafi Ahmed
Journal:  Int Immunol       Date:  2010-08-23       Impact factor: 4.823

4.  Genome-wide profiling of DNA methylation reveals preferred sequences of DNMTs in hepatocellular carcinoma cells.

Authors:  Hong Fan; Zhujiang Zhao; Yuchao Cheng; He Cui; Fengchang Qiao; Ling Wang; Jiaojiao Hu; Huzhang Wu; Wei Song
Journal:  Tumour Biol       Date:  2015-08-09

5.  S-Adenosylhomocysteine hydrolase deficiency: a second patient, the younger brother of the index patient, and outcomes during therapy.

Authors:  I Barić; M Cuk; K Fumić; O Vugrek; R H Allen; B Glenn; M Maradin; L Pazanin; I Pogribny; M Rados; V Sarnavka; A Schulze; S Stabler; C Wagner; S H Zeisel; S H Mudd
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

6.  Regulation of demethylation and re-expression of RASSF1A gene in gastric cancer cell lines by combined treatment of 5-Aza-CdR and NaB.

Authors:  Wen-Jing Shen; Dong-Qiu Dai; Yue Teng; Hong-Bo Liu
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

Review 7.  Epigenetic system: a pathway to malignancies and a therapeutic target.

Authors:  Mitsuyoshi Nakao; Takeshi Minami; Yasuaki Ueda; Yasuo Sakamoto; Takaya Ichimura
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

8.  Enzymatic methylation of DNA in cultured human cells studied by stable isotope incorporation and mass spectrometry.

Authors:  Jason L Herring; Daniel K Rogstad; Lawrence C Sowers
Journal:  Chem Res Toxicol       Date:  2009-06       Impact factor: 3.739

9.  DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas.

Authors:  Anne Y Lai; Mehrnaz Fatemi; Archana Dhasarathy; Christine Malone; Steve E Sobol; Cissy Geigerman; David L Jaye; Deepak Mav; Ruchir Shah; Leping Li; Paul A Wade
Journal:  J Exp Med       Date:  2010-08-23       Impact factor: 14.307

10.  Methylation of a CpG island within the uroplakin Ib promoter: a possible mechanism for loss of uroplakin Ib expression in bladder carcinoma.

Authors:  Andrea E Varga; Lefta Leonardos; Paul Jackson; Alexandra Marreiros; Prue A Cowled
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.